Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacophore-Based Machine Learning Model To Predict Ligand Selectivity for E3 Ligase Binders. | ACS Omega | 2023 | 37636935 | PubTator, text mining | PubMed |
| The Magic Methyl and Its Tricks in Drug Discovery and Development. | Pharmaceuticals (Basel) | 2023 | 37631072 | PubTator, text mining | PubMed |
| Central Nervous System Targeted Protein Degraders. | Biomolecules | 2023 | 37627229 | PubTator, text mining | PubMed |
| Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study. | Cancers (Basel) | 2023 | 37627065 | PubTator, text mining | PubMed |
| Coming of Age: Targeting Cyclin K in Cancers. | Cells | 2023 | 37626854 | PubTator, text mining | PubMed |
| Beyond Bruton's tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody-drug conjugates, CAR T-cells, and novel agents. | J Hematol Oncol | 2023 | 37626420 | PubTator, text mining | PubMed |
| Synthesis and Evaluation of Cereblon-Recruiting HaloPROTACs. | Chembiochem | 2023 | 37625128 | PubTator, text mining | PubMed |
| Editorial: Proteomic and metabolic reprogramming in myeloma cells within the tumor microenvironment. | Front Oncol | 2023 | 37609386 | PubTator, text mining | PubMed |
| A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov. | Discov Oncol | 2023 | 37603124 | PubTator, text mining | PubMed |
| Targeted Protein Degradation: Advances, Challenges, and Prospects for Computational Methods. | J Chem Inf Model | 2023 | 37602861 | PubTator, text mining | PubMed |
| Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation. | Nat Commun | 2023 | 37596276 | PubTator, text mining | PubMed |
| Opportunities and challenges of protein-based targeted protein degradation. | Chem Sci | 2023 | 37592990 | PubTator, text mining | PubMed |
| Elucidation of genome-wide understudied proteins targeted by PROTAC-induced degradation using interpretable machine learning. | PLoS Comput Biol | 2023 | 37590332 | PubTator, text mining | PubMed |
| c-FOS is an integral component of the IKZF1 transactivator complex and mediates lenalidomide resistance in multiple myeloma. | Clin Transl Med | 2023 | 37581569 | PubTator, text mining | PubMed |
| HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation. | Cell Chem Biol | 2023 | 37572669 | PubTator, text mining | PubMed |
| Design, synthesis and evaluation of EZH2-based PROTACs targeting PRC2 complex in lymphoma. | Bioorg Chem | 2023 | 37572533 | PubTator, text mining | PubMed |
| Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs. | Molecules | 2023 | 37570820 | PubTator, text mining | PubMed |
| Significance of Five-Membered Heterocycles in Human Histone Deacetylase Inhibitors. | Molecules | 2023 | 37570656 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs. | Int J Mol Sci | 2023 | 37569792 | PubTator, text mining | PubMed |
| EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs. | Int J Mol Sci | 2023 | 37569677 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=31